In Vitro Activity of Fidaxomicin (OPT-80) Tested against Contemporary Clinical Isolates of Staphylococcus spp. and Enterococcus spp.

被引：27
|
作者：
Biedenbach, Douglas J. [1 ]
Ross, James E. [1 ]
Putnam, Shannon D. [1 ]
Jones, Ronald N. [1 ]
机构：
[1] JMI Labs, Iowa City, IA 52317 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2010年 / 54卷 / 05期
关键词：
VANCOMYCIN-RESISTANT ENTEROCOCCI; CLOSTRIDIUM-DIFFICILE INFECTION; ORAL METRONIDAZOLE; DISEASE;
D O I：
10.1128/AAC.00090-10
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：2273 / 2275
页数：3
相关论文
共 50 条
  • [21] Weak Cytotoxic Activity of Miltefosine Against Clinical Isolates of Acanthamoeba spp.
    Mrva, M.
    Garajova, M.
    Lukac, M.
    Ondriska, F.
    JOURNAL OF PARASITOLOGY, 2011, 97 (03) : 538 - 540
  • [22] In vitro activity of OPT-80 against clostridium difcile
    Ackermann, G
    Löffler, B
    Adler, D
    Rodloff, AC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) : 2280 - 2282
  • [23] In vitro evaluation of the antagonistic activity of native strains of Trichoderma spp. against Fusarium spp.
    Martinez-Padron, Hadassa Yuef
    Herrera-Mayorga, Veronica
    Alejandro Paredes-Sanchez, Francisco
    Eduardo Lara-Ramirez, Edgar
    Ariel Torres-Castillo, Jorge
    Rodriguez-Herrera, Raul
    Alberto Lopez-Santillan, Jose
    Osorio-Hernandez, Eduardo
    JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART B-PESTICIDES FOOD CONTAMINANTS AND AGRICULTURAL WASTES, 2023, 58 (02) : 195 - 202
  • [24] The Evaluation of Different Bacteriocinogenic Bacillus spp. with Activity Against Staphylococcus spp. and Their Beneficial and/or Hazardous Properties
    Fugaban, Joanna Ivy Irorita
    Dioso, Clarizza May
    Choi, Gee Hyeun
    Bucheli, Jorge Enrique Vazquez
    Liong, Min-Tze
    Holzapfel, Wilhelm Heinrich
    Todorov, Svetoslav Dimitrov
    PROBIOTICS AND ANTIMICROBIAL PROTEINS, 2024, 16 (01) : 35 - 52
  • [25] In Vitro Activity of Tigecycline Against Brucella spp.
    Altun, Belgin
    Hascelik, Guelsen
    Gur, Deniz
    TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI, 2009, 26 (03): : 261 - 263
  • [26] In vitro activity of garenoxacin against Chlamydia spp.
    Hisada, H.
    Yamazaki, T.
    Inoue, M.
    Sato, K.
    Ando, S.
    Kishimoto, T.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (02) : 282 - 284
  • [27] The effect of natural antimicrobials against Campylobacter spp. and its similarities to Salmonella spp, Listeria spp., Escherichia coli, Vibrio spp., Clostridium spp. and Staphylococcus spp
    Balta, Igori
    Linton, Mark
    Pinkerton, Laurette
    Kelly, Carmel
    Stef, Lavinia
    Pet, Ioan
    Stef, Ducu
    Criste, Adriana
    Gundogdu, Ozan
    Corcionivoschi, Nicolae
    FOOD CONTROL, 2021, 121
  • [28] In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
    Barchiesi, F
    Tortorano, AM
    Di Francesco, LF
    Cogliati, M
    Scalise, G
    Viviani, MA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (02) : 295 - 299
  • [29] In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp.
    Compain, Fabrice
    Botterel, Francoise
    Sitterle, Emilie
    Paugam, Andre
    Bougnoux, Marie-Elisabeth
    Dannaoui, Eric
    JOURNAL OF MEDICAL MICROBIOLOGY, 2015, 64 : 309 - 311
  • [30] In vitro susceptibility of Aspergillus spp. clinical isolates to albendazole
    Berthet, N
    Faure, O
    Bakri, A
    Ambroise-Thomas, P
    Grillot, R
    Brugère, JF
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (06) : 1419 - 1422
12345